Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DELAT PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionMorgan Stanley
Latest Disclosed Ownership8,527,037 shares
Latest Disclosed Value $ 1,302,505,395
Morgan Stanley reports 3.94% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 8,527,037 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $1,095,724,254 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 8,876,906 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -3.94% during the quarter. The current value of the position is $1,031,771,477 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 8,527,037 -349,869 -3.94 1,302,505 6.43 0.0785
2026-05-27 2025-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 8,876,906 1,148,033 14.85 1,223,860 23.48 0.0731
2026-02-13 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,876,906 1,148,033 1,223,860 0.0731
2026-05-27 2025-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 7,728,873 169,385 2.24 991,151 8.35 0.0600
2025-11-14 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,728,873 169,385 991,151 0.0600
2025-08-15 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,559,488 503,577 7.14 914,774 16.30 0.0596
2025-05-15 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,055,911 186,756 2.72 786,593 17.68 0.0562
2025-05-15 2024-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 6,869,155 -115,717 -1.66 668,438 -16.80 0.0468
2025-02-14 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,869,155 -115,717 668,438 0.0468
2025-05-14 2024-09-30 13F/A-2 NOVARTIS SPONSORED ADR 66987V109 6,984,872 -431,807 -5.82 803,400 1.75 0.0583
2025-02-14 2024-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 6,984,872 -431,807 803,400 0.0582
2024-11-14 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,984,872 -431,807 803,400 0.0582
2025-05-14 2024-06-30 13F/A-2 NOVARTIS SPONSORED ADR 66987V109 7,416,679 158,298 2.18 789,580 12.46 0.0611
2024-10-17 2024-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 7,416,679 158,298 789,580 0.0611
2024-08-14 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,416,679 158,298 789,580 0.0611
2024-10-17 2024-03-31 13F/A-2 NOVARTIS SPONSORED ADR 66987V109 7,258,381 166,128 2.34 702,104 -1.96 0.0563
2024-08-16 2024-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 7,258,381 166,128 702,104 0.0066
2024-05-15 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,258,381 166,128 702,104 0.0563
2024-08-16 2023-12-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 7,092,253 114,420 1.64 716,105 0.75 0.0631
2024-02-13 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,092,253 114,420 716,105 0.0631
2023-11-15 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,977,833 -287,598 -3.96 710,762 -3.05 0.0723
2023-08-14 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,265,431 650,965 9.84 733,155 20.48 0.0723
2023-05-15 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,614,466 126,270 1.95 608,531 3.38 0.0652
2023-02-14 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,488,196 377,693 6.18 588,609 26.73 0.0669
2022-11-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,110,503 -288,283 -4.51 464,459 -14.13 0.0633
2022-10-27 2022-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 6,398,786 3,134,810 96.04 540,890 88.85 0.0702
2022-08-15 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,398,786 3,134,810 540,890 0.0702
2022-10-27 2022-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 3,263,976 -219,673 -6.31 286,415 -6.01 0.0386
2022-05-13 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,263,976 -219,673 286,415 0.0386
2022-02-14 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,483,649 267,670 8.32 304,714 15.86 0.0376
2021-11-15 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,215,979 256,018 8.65 263,003 -2.62 0.0354
2021-08-23 2021-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 2,959,961 119,862 4.22 270,066 11.24 0.0356
2021-08-16 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,959,961 119,862 270,066 0.0074
2021-05-17 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,840,099 31,106 1.11 242,772 -8.48 0.0357
2021-02-16 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,808,993 263,445 10.35 265,253 19.83 0.0410
2020-11-13 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,545,548 -143,207 -5.33 221,361 -5.74 0.0428
2020-08-14 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,688,755 -1,067,159 -28.41 234,836 -24.17 0.0520
2020-05-26 2020-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 3,755,914 965,770 34.61 309,675 17.21 0.0842
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,755,914 965,770 309,675 23,789.4956
2020-02-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,790,144 357,703 14.71 264,198 24.99 0.0614
2019-11-14 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,432,441 23,073 0.96 211,379 -3.92 0.0560
2019-08-14 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,409,368 -673,995 -21.86 219,999 -25.78 0.0586
2019-05-15 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,083,363 198,176 6.87 296,433 19.73 0.0839
2019-02-14 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,885,187 -53,418 -1.82 247,578 -2.22 0.0741
2019-04-23 2018-09-30 13F/A-2 NOVARTIS A G SPONSORED ADR 66987V109 2,938,605 34,696 1.19 253,191 15.42 0.0634
2018-11-20 2018-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 2,938,605 0 253,191 0.0634
2018-11-14 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,938,605 34,696 253,191
2019-04-23 2018-06-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 2,903,909 -18,812 -0.64 219,362 -7.17 0.0593
2018-08-14 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,903,909 -18,812 219,362
2019-04-23 2018-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 2,922,721 296,995 11.31 236,303 7.19 0.0656
2018-05-14 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,922,721 296,995 236,303
2019-04-23 2017-12-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 2,625,726 300,795 12.94 220,455 10.45 0.0603
2018-02-14 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,625,726 300,795 220,455
2017-11-14 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,324,931 495,364 27.08 199,595 30.70 0.0598
2017-08-11 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,829,567 -104,326 -5.39 152,714 6.32 0.0461
2017-05-22 2017-03-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 1,933,893 124,428 6.88 143,630 8.97 0.0441
2017-05-12 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,933,893 143,630
2017-02-22 2016-12-31 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 1,809,465 -27,051 -1.47 131,801 -9.11 0.0431
2017-02-13 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,809,465 131,801
2016-11-10 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,836,516 58,019 3.26 145,012 -1.18 0.0495
2016-08-12 2016-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,778,497 -21,373 -1.19 146,745 12.55 0.0530
2016-05-12 2016-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,799,870 -25,855 -1.42 130,383 -17.00 0.0502
2016-02-09 2015-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,825,725 -274,035 -13.05 157,085 -18.61 0.0569
2016-02-08 2015-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 2,099,760 -129,958 -5.83 193,010 -11.98 0.0713
2015-11-09 2015-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,099,760 193,010
2015-08-12 2015-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 2,229,718 330,988 17.43 219,271 17.11 0.0760
2015-05-14 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,898,730 -175,765 -8.47 187,235 -2.59 0.0690
2015-02-13 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,074,495 221,472 11.95 192,222 10.20 0.0703
2014-12-16 2014-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 1,853,023 19,507 1.06 174,427 11.89 0.0671
2014-11-14 2014-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 1,853,023 174,427
2014-05-13 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 1,833,516 -328,930 -15.21 155,886 -10.32 0.0653
2014-02-13 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,162,446 237,468 12.34 173,817 17.71 0.0739
2013-11-13 2013-09-30 13F NOVARTIS INC BASLE ADR ADRS 66987V109 1,924,978 -1,928,230 -50.04 147,665 -45.80 0.0698
2013-08-08 2013-06-30 13F NOVARTIS INC BASLE ADR ADRS 66987V109 3,853,208 3,853,208 272,459 0.1374
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.